Clovis Oncology
CLVS
#10870
Rank
S$15.18 M
Marketcap
S$0.10
Share price
0.00%
Change (1 day)
-95.14%
Change (1 year)

Earnings for Clovis Oncology (CLVS)

Earnings in 2022 (TTM): -S$0.31 Billion

According to Clovis Oncology's latest financial reports the company's current earnings are S$0.13 Billion. In 2021 the company made an earning of -S$0.31 Billion, an increase over its 2020 earnings that were of -S$0.45 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clovis Oncology from 2010 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -S$0.31 Billion-0.2%
2021 -S$0.31 Billion-32.64%
2020 -S$0.45 Billion-9.06%
2019 -S$0.5 Billion7.49%
2018 -S$0.46 Billion4.42%
2017 -S$0.44 Billion-8.83%
2016 -S$0.48 Billion-0.4%
2015 -S$0.49 Billion140.82%
2014 -S$0.21 Billion86.64%
2013 -S$0.11 Billion19.53%
2012 -S$89.7 Million
2010 -S$34.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$24.15 B-8,711.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$8.98 B-3,305.09%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$16.53 B-5,994.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$44.85 B-16,092.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$19.46 B-7,040.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
BioMarin Pharmaceutical
BMRN
S$56.32 M-120.08%๐Ÿ‡บ๐Ÿ‡ธ USA